Related Experiment Video

Updated: Jul 4, 2026

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid
10:42

Ex Vivo Expansion of Hematopoietic Stem Cells from Human Umbilical Cord Blood-derived CD34+ Cells Using Valproic Acid

Published on: April 11, 2019

New insights into cord blood stem cell transplantation

William Tse1, Kevin D Bunting, Mary J Laughlin

  • 1Division of Medical Oncology, Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado, USA

Current Opinion in Hematology
|June 10, 2008
PubMed

Insights

Allogeneic umbilical cord blood stem cell transplantation shows promise as a frontline treatment for pediatric leukemia, offering superior survival rates. Advances also enhance its use in adults, expanding treatment options for hematologic disorders.

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Stem Cell Biology

Background:

  • Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells (HSCs).
  • Allogeneic transplantation is a critical treatment for hematologic malignancies and other disorders.
  • Advances in HSC transplantation continue to improve patient outcomes.

Purpose of the Study:

  • To review clinical and biological advancements in allogeneic UCB stem cell transplantation.
  • To assess the current role and future potential of UCB transplantation in pediatric and adult patients.

Main Methods:

  • Review of recent international clinical studies.
  • Analysis of biological research on UCB stem cell properties.
  • Evaluation of engraftment strategies and transplantation outcomes.

Main Results:

  • UCB transplantation may become the primary HSC source for pediatric leukemia, showing better survival than marrow stem cells.
  • In adults, UCB transplantation, double UCB units, and nonmyeloablative strategies are gaining traction.
  • Biological research is developing enhanced engraftment approaches for UCB HSCs.

Conclusions:

  • UCB is a valuable HSC source for allogeneic transplantation when matched donors are unavailable.
  • Ongoing clinical and biological research will broaden UCB transplantation applications for hematologic disorders in all age groups.
Abstract

More Related Videos

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis06:28

Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

Published on: November 10, 2023

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...